EN
HI
Summary
As of 18 Sep, 2026, Alivus Life Sciences stock price is ₹1430.8. During the trading session, the stock has moved between an intraday low of ₹1387.00 and an intraday high of ₹1443.00. Over the last 52 weeks, Alivus Life Sciences has traded between ₹819.00 and ₹1493.80.
The stock has recorded a trading volume of 3,04,330 shares,. Its Average Traded Price (ATP) is ₹1423.36, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 28 @ ₹1430.80.
Alivus Life Sciences has an upper circuit limit of ₹1665.30 and a lower circuit limit of ₹1110.30. The total value traded stands at ₹43.32 CR, and the delivery percentage for the day is 56.44%.
The stock is currently traded with a market lot size of 1. Alivus Life Sciences also offers a dividend yield of 0%.
Alivus Life Sciences Share Price Chart
Alivus Life Sciences Share Key Metrics
Volume
3.04 L
Market Cap
17561.56 CR
LTQ@LTP
28@1430.80
ATP
1423.36
Var Margin
16.77 %
Circuit Range
1110.3-1665.3
Delivery %
56.44 %
Value
43.32 CR
ASM/GSM
No
Market Lot
1
Alivus Life Sciences Resistance and Support
Pivot 1382.27
Resistance
First Resistance
1403.44
Second Resistance
1419.07
Third Resistance
1440.24
Support
First Support
1366.64
Second Support
1345.47
Third Support
1329.84
Alivus Life Sciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 1395.1 | 1430.8 | 3.10% | 1443 | 1387 |
| Thu Sep 17 2026 | 1372.8 | 1387.8 | 1.26% | 1397.9 | 1361.09 |
| Wed Sep 16 2026 | 1350 | 1370.59 | 1.69% | 1390.9 | 1317.59 |
Alivus Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-14 | Audited Results & Final Dividend |
| 2026-01-22 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-24 | Quarterly Results |
Alivus Life Sciences News
Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Alivus Life Sciences announced upcoming one-on-one meetings with institutional investors and analysts including Breakout Capital, UTI, Kotak Mutual Fund, and Param Capital. These in-person meetings are scheduled for September 9, 2026, in Mumbai.
Sep 05 2026 20:15:41
Alivus Life Sciences Management
| Name | Position |
|---|---|
| Rudalf Corriea | Company Secretary & Compliance Officer |
| Hiren K Patel | Chairman |
Alivus Life Sciences Similar Stocks
Rainbow Children's Medicare Ltd.
1454.70
-18.70 (1.27%)
Natco Pharma Ltd.
813.40
-4.85 (0.59%)
Marksans Pharma Ltd.
320.15
0.45 (0.14%)
CORONA Remedies Ltd.
2201.80
32.20 (1.48%)
Sudeep Pharma Ltd.
1155.00
49.60 (4.49%)
Akums Drugs & Pharmaceuticals Ltd.
783.70
17.00 (2.22%)
Metropolis Healthcare Ltd.
597.45
11.15 (1.90%)
Park Medi World Ltd.
282.05
4.15 (1.49%)
Sanofi Consumer Healthcare India Ltd.
4033.40
43.90 (1.10%)
Strides Pharma Science Ltd.
1219.80
19.60 (1.63%)
Alivus Life Sciences FAQs
The Buying Price of Alivus Life Sciences share is 1430.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alivus Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alivus Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alivus Life Sciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alivus Life Sciences shares is 0. Useful to assess the stock's value relative to its book value.
To assess Alivus Life Sciences’s valuation compare Sector P/E, P/B which are 40.93 & 3.56 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alivus Life Sciences is 17561.56 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alivus Life Sciences share price is 1493.80 & 819.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alivus Life Sciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ALIVUS
